13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001569064
Total reported value
$5.5B
$5.5B
101 檔
14.6%
In Q1 2024, Montanova Capital, LLC's U.S. equity holdings reached a combined market value of $5.5B, distributed across 101 disclosed stock positions.
Montanova Capital, LLC executed strategic sector rebalancing during Q1 2024, establishing 13 new positions while fully exiting 5 holdings and trimming 20 positions.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | SPY | Ss Spdr S&p 500 ETF Trust-us | ETF-Large Cap & Growth | 8.74% | +7.16% | — | |
| 2 | BHVN | Biohaven Ltd. | Stock-Other | 8.13% | +0.58% | -12.46% | |
| 3 | KURA | Kura Oncology Inc | Stock-Other | 5.60% | -0.06% | +1.78% | |
| 4 | ACLXGBX | Arcellx Inc | Stock-Other | 4.04% | — | -35.86% | |
| 5 | QQQ | Invesco Qqq Trust Series 1 | ETF-Tech | 3.22% | — | — | |
| 6 | META | Meta Platforms Inc-class A | Stock-Comm Services | 3.13% | -0.67% | -21.15% | |
| 7 | RARE | Ultragenyx Pharmaceutical In | Stock-Other | 2.91% | — | -21.14% | |
| 8 | ARQT | Arcutis Biotherapeutics Inc | Stock-Other | 2.90% | -1.46% | -7.03% | |
| 9 | EYPT | Eyepoint Inc | Stock-Other | 2.89% | -0.56% | -7.22% | |
| 10 | ETNBGBP | 89bio Inc | Stock-Other | 2.72% | — | +28.83% | |
| 11 | RPRX | Royalty Pharma plc | Stock-Healthcare | 2.54% | — | -42.12% | |
| 12 | ITCIEUR | Intra-cellular Therapies Inc | Stock-Other | 2.47% | — | -17.73% | |
| 13 | AMZN | Amazon.com Inc | Stock-Consumer Disc | 2.39% | -0.46% | -3.02% | |
| 14 | AMD | Advanced Micro Devices | Stock-Tech | 2.29% | +1.39% | +2.47% | |
| 15 | INSM | Insmed Inc | Stock-Healthcare | 2.04% | — | -24.64% | |
| 16 | CI | THE Cigna Group | Stock-Healthcare | 1.85% | — | +42.41% | |
| 17 | 4XC1 | Kalvista Pharmaceuticals Inc | Stock-Other | 1.85% | -2.45% | EXIT | |
| 18 | VZ | Verizon Communications Inc | Stock-Comm Services | 1.84% | — | +64.53% | |
| 19 | ARGX | Argenx Se - Adr | Stock-Healthcare | 1.78% | — | +127.00% | |
| 20 | MRNS* | Marinus Pharmaceuticals Inc | Stock-Other | 1.72% | — | -4.44% | |
| 21 | GS | Goldman Sachs Group Inc | Stock-Financials | 1.70% | — | -0.38% | |
| 22 | TSM | Taiwan Semiconductor-sp Adr | Stock-Tech | 1.66% | +0.08% | -15.17% | |
| 23 | T | At&t Inc | Stock-Comm Services | 1.57% | — | +96.60% | |
| 24 | APO | Apollo Global Management Inc | Stock-Financials | 1.55% | -0.27% | -31.47% | |
| 25 | FERG | Ferguson Enterprises Inc. | Stock-Industrials | 1.37% | — | -3.87% | |
| 26 | GE | General Electric | Stock-Industrials | 1.35% | -0.13% | -41.76% | |
| 27 | KO | Coca-cola Co/the | Stock-Consumer Staples | 1.24% | — | — | |
| 28 | MSFT | Microsoft CORP | Stock-Tech | 1.24% | -0.02% | -51.02% | |
| 29 | STRO | Sutro Biopharma, Inc. | Stock-Other | 1.21% | — | — | |
| 30 | MCK | Mckesson CORP | Stock-Healthcare | 1.13% | -0.01% | -10.75% | |
| 31 | AAPL | Apple Inc | Stock-Tech | 1.13% | — | — | |
| 32 | CRH | CRH plc | Stock-Materials | 1.08% | — | — | |
| 33 | AVBP | Arrivent Biopharma Inc | Stock-Other | 1.04% | +0.28% | — | |
| 34 | FULC | Fulcrum Therapeutics Inc | Stock-Other | 1.00% | -1.04% | -48.39% | |
| 35 | ELV | Elevance Health Inc | Stock-Healthcare | 0.98% | — | -5.23% | |
| 36 | ORCL | Oracle CORP | Stock-Tech | 0.92% | — | -38.93% | |
| 37 | CMG | Chipotle Mexican Grill Inc | Stock-Consumer Disc | 0.86% | — | -8.50% | |
| 38 | BCYC | Bicycle Therapeutics Plc-adr | Stock-Other | 0.85% | — | — | |
| 39 | PEPG | Pepgen Inc | Stock-Other | 0.83% | — | +212.56% | |
| 40 | BSX | Boston Scientific CORP | Stock-Healthcare | 0.77% | -0.09% | -56.34% | |
| 41 | FATE | Fate Therapeutics Inc | Stock-Other | 0.70% | — | — | |
| 42 | RCUS | Arcus Biosciences Inc | Stock-Other | 0.67% | -0.09% | — | |
| 43 | HLT | Hilton Worldwide Holdings In | Stock-Consumer Disc | 0.62% | — | -28.15% | |
| 44 | CRM | Salesforce Inc | Stock-Tech | 0.62% | — | — | |
| 45 | SBUX | Starbucks CORP | Stock-Consumer Disc | 0.59% | — | — | |
| 46 | JNJ | Johnson & Johnson | Stock-Healthcare | 0.53% | -0.11% | — | |
| 47 | GPN | Global Payments Inc | Stock-Industrials | 0.53% | — | -5.59% | |
| 48 | PINS | Pinterest Inc- Class A | Stock-Comm Services | 0.51% | — | — | |
| 49 | MREO | Mereo Biopharma Group Pl-adr | Stock-Other | 0.45% | — | -50.43% | |
| 50 | SNY | Sanofi-adr | Stock-Healthcare | 0.38% | — | +23.22% |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | SPY | Ss Spdr S&p 500 ETF Trust-us | +8.7% | NEW | New buy |
| 2 | QQQ | Invesco Qqq Trust Series 1 | +3.2% | NEW | New buy |
| 3 | ARQT | Arcutis Biotherapeutics Inc | +1.7% | -7.03% | Trim |
| 4 | KO | Coca-cola Co/the | +1.2% | NEW | New buy |
| 5 | AAPL | Apple Inc | +1.1% | NEW | New buy |
| 6 | KURA | Kura Oncology Inc | +1.1% | +1.78% | Add |
| 7 | CRH | CRH plc | +1.1% | NEW | New buy |
| 8 | AVBP | Arrivent Biopharma Inc | +1% | NEW | New buy |
| 9 | ARGX | Argenx Se - Adr | +0.9% | +127.00% | Add |
| 10 | FATE | Fate Therapeutics Inc | +0.7% | NEW | New buy |
| 11 | PEPG | Pepgen Inc | +0.7% | +212.56% | Add |
| 12 | T | At&t Inc | +0.6% | +96.60% | Add |
| 13 | VZ | Verizon Communications Inc | +0.6% | +64.53% | Add |
| 14 | CRM | Salesforce Inc | +0.6% | NEW | New buy |
| 15 | SBUX | Starbucks CORP | +0.6% | NEW | New buy |
| 16 | CI | THE Cigna Group | +0.6% | +42.41% | Add |
| 17 | PINS | Pinterest Inc- Class A | +0.5% | NEW | New buy |
| 18 | ✓ | Immatics NV | +0.4% | NEW | New buy |
| 19 | 4XC1 | Kalvista Pharmaceuticals Inc | +0.4% | +56.18% | Add |
| 20 | RVNCEUR | Revance Therapeutics Inc | +0.3% | NEW | New buy |
| 21 | ETNBGBP | 89bio Inc | +0.3% | +28.83% | Add |
| 22 | GEHC | GE Healthcare Technology | +0.3% | NEW | New buy |
| 23 | BCYC | Bicycle Therapeutics Plc-adr | +0.1% | — | Unchanged |
| 24 | STRO | Sutro Biopharma, Inc. | +0.1% | — | Unchanged |
| 25 | AMD | Advanced Micro Devices | +0.1% | +2.47% | Add |
| 26 | AMZN | Amazon.com Inc | -0.1% | -3.02% | Trim |
| 27 | SANA | Sana Biotechnology Inc | -0.3% | EXIT | Sold out |
| 28 | MREO | Mereo Biopharma Group Pl-adr | -0.3% | -50.43% | Trim |
| 29 | ✓ | Zura Bio LTD | -0.3% | — | Unchanged |
| 30 | ANAB | Anaptysbio Inc | -0.3% | EXIT | Sold out |
| 31 | META | Meta Platforms Inc-class A | -0.4% | -21.15% | Trim |
| 32 | AGIO | Agios Pharmaceuticals Inc | -0.4% | EXIT | Sold out |
| 33 | ORCL | Oracle CORP | -0.6% | -38.93% | Trim |
| 34 | FULC | Fulcrum Therapeutics Inc | -0.7% | -48.39% | Trim |
| 35 | GE | General Electric | -0.7% | -41.76% | Trim |
| 36 | BHVN | Biohaven Ltd. | -0.7% | -12.46% | Trim |
| 37 | APO | Apollo Global Management Inc | -0.7% | -31.47% | Trim |
| 38 | COGT | Cogent Biosciences Inc | -0.9% | -91.48% | Trim |
| 39 | MRNS* | Marinus Pharmaceuticals Inc | -0.9% | -4.44% | Trim |
| 40 | BSX | Boston Scientific CORP | -1% | -56.34% | Trim |
| 41 | KWEB | Kranesh Csi China Internet | -1.1% | EXIT | Sold out |
| 42 | ITCIEUR | Intra-cellular Therapies Inc | -1.3% | -17.73% | Trim |
| 43 | EYPT | Eyepoint Inc | -1.4% | -7.22% | Trim |
| 44 | 430 | Terns Pharmaceuticals Inc | -1.4% | -76.64% | Trim |
| 45 | MSFT | Microsoft CORP | -1.5% | -51.02% | Trim |
| 46 | LVS | Las Vegas Sands CORP | -1.6% | EXIT | Sold out |
| 47 | RARE | Ultragenyx Pharmaceutical In | -1.7% | -21.14% | Trim |
| 48 | INSM | Insmed Inc | -1.7% | -24.64% | Trim |
| 49 | ACLXGBX | Arcellx Inc | -2.1% | -35.86% | Trim |
| 50 | RPRX | Royalty Pharma plc | -2.4% | -42.12% | Trim |
According to official SEC Form 13F filings, Montanova Capital, LLC reported a total U.S. public equity portfolio value of $5.5B across 101 disclosed positions in Q1 2024.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including SPY, BHVN, KURA) accounted for 14.6% of total reported equity market value during Q1 2024.
Top New Position Initiated
SPY
市值: $235.4M
Top Position Liquidated / Trimmed
LVS
前期市值: $36.3M
During Q1 2024, Montanova Capital, LLC's top holdings by market value included SPY (8.7%)、BHVN (8.1%)、KURA (5.6%). The largest single position, SPY, represented 8.7% of total portfolio value.
In Q1 2024, Montanova Capital, LLC made 47 total portfolio adjustments, initiating 13 new buys, adding to 9 positions, trimming 20 holdings, and fully liquidating 5 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.